Hayes Christopher G.

Insider profile

Performance

Overall performance
3.4

Performance over holding periods
4.2
30 days 90 days 120 days
Average return 16% 8.2% 15.1%
Success rate 82% 68% 82%
Transactions
10 20% Buy
34 71% Buy
47 69% Buy
Performance for realised trades
4.4
Average return 70%
Success rate 73%
Average holding period 220
Transactions 28
Hayes Christopher G.'s trades of Verrica Pharmaceuticals Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2025-03-18 2025-03-17 S Sale
1,722 -11.6%
460.46
US$2,717,863
1,722 -11.6% 460.46 US$2,717,863
2024-08-28 2024-08-27 S Sale
74,782 -44.7%
475.01
US$382,429
74,782 -44.7% 475.01 US$382,429
2024-08-28 2024-08-26 S Sale
29,775 +12.9%
350.17
US$1,905,857
29,775 +12.9% 350.17 US$1,905,857
2024-08-26 2024-08-26 PrS Proposed sale
36,000
2.62
US$94,300
36,000 2.62 US$94,300
2024-07-23 2024-07-23 S Sale
91 -0.1%
6.98
US$635
91 -0.1% 6.98 US$635
2024-07-23 2024-07-22 S Sale
21,649 -13.3%
7.06
US$152,842
21,649 -13.3% 7.06 US$152,842
2024-07-22 2024-07-22 PrS Proposed sale
21,971
6.97
US$153,085
21,971 6.97 US$153,085
2023-11-16 2023-11-15 S Sale
11,558 -8.6%
2.97
US$34,327
11,558 -8.6% 2.97 US$34,327
2023-11-16 2023-11-14 S Sale
22,141 -14.1%
2.93
US$64,873
22,141 -14.1% 2.93 US$64,873
2023-11-15 2023-11-14 PrS Proposed sale
33,798
2.93
US$99,028
33,798 2.93 US$99,028
2023-07-27 2023-07-24 PrS Proposed sale
33,789
4.80
US$162,285
33,789 4.80 US$162,285
2023-07-25 2023-07-24 S Sale
33,789 -29.2%
4.83
US$163,201
33,789 -29.2% 4.83 US$163,201
2022-07-11 2022-07-11 B Purchase
7,500 +91.3%
3.40
US$25,500
7,500 +91.3% 3.40 US$25,500
2022-07-05 2022-07-05 B Purchase
5,714 +228.6%
2.10
US$11,999
5,714 +228.6% 2.10 US$11,999